Clinuvel Pharmaceuticals Limited (ASX:CUV) Directors Insider Transactions
The Directors and Chief Executives of Clinuvel Pharmaceuticals Limited (ASX:CUV) are required by law to report any insider transaction activities i.e. buying, selling, option exercising the Clinuvel Pharmaceuticals Limited's shares in the stock market. Below table shows the list of insider transactions as reported by Clinuvel Pharmaceuticals Limited to the ASX stock exchange.
An insider trade occurs when an individual (such as a CEO, CFO or COO) that has non-public information about a company buys or sells shares of that company's stock. Tracking a company's insider trades is a metric that can be used to identify the direction that the company's executives believes that the company is headed. For example, if a number of insiders purchase more shares of a company, they may believe that the company will have strong future earnings and that the share price will increase in the near future.
Clinuvel Pharmaceuticals Limited Directors/Insider Transactions Activity
List of Insider trades activity from Clinuvel Pharmaceuticals Limited (CUV).
| Date | Director | Director's Title | Shares | Value | Note |
|---|---|---|---|---|---|
| 12 Aug 2025 | Wright (Dennis J) | Divisional Officer | 3,500 | - | - |
| 30 Jun 2025 | Vaughan (Peter) | Chief Financial Officer | 3,500 | - | - |
| 16 Oct 2024 | Shanahan (Brenda Mary) | Former | 80,000 | - | - |
| 03 Oct 2024 | Agersborg (Karen) | Director (Non-Executive) | 8,333 | 87,877 | Other at price 10.55 per share. |
| 30 Jun 2024 | Keamy (Darren M) | Chief Financial Officer | 184,302 | - | - |
| 30 Jun 2024 | Wright (Dennis J) | Divisional Officer | 31,938 | - | - |